Starlake Bioscience Co Inc Zhaoqing Guangdong

SHG:600866 China Biotechnology
Market Cap
$1.82 Billion
CN¥13.37 Billion CNY
Market Cap Rank
#7365 Global
#1243 in China
Share Price
CN¥8.05
Change (1 day)
+0.25%
52-Week Range
CN¥6.03 - CN¥8.39
All Time High
CN¥9.46
About

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an interme… Read more

Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.147x

Based on the latest financial reports, Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a cash flow conversion efficiency ratio of 0.147x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.25 Billion) by net assets (CN¥8.50 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Starlake Bioscience Co Inc Zhaoqing Guangdong - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Starlake Bioscience Co Inc Zhaoqing Guangdong Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starlake Bioscience Co Inc Zhaoqing Guangdong ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2024)

The table below shows the annual cash flow conversion efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥8.03 Billion CN¥2.40 Billion 0.299x +12.86%
2023-12-31 CN¥7.66 Billion CN¥2.03 Billion 0.265x +10.25%
2022-12-31 CN¥6.93 Billion CN¥1.66 Billion 0.240x +121.16%
2021-12-31 CN¥1.78 Billion CN¥192.63 Million 0.108x -27.57%
2020-12-31 CN¥1.67 Billion CN¥249.99 Million 0.150x +6.82%
2019-12-31 CN¥1.52 Billion CN¥213.17 Million 0.140x +164.58%
2018-12-31 CN¥956.42 Million CN¥50.69 Million 0.053x +20.96%
2017-12-31 CN¥914.14 Million CN¥40.05 Million 0.044x +14.12%
2016-12-31 CN¥1.07 Billion CN¥41.17 Million 0.038x +1365.65%
2015-12-31 CN¥1.05 Billion CN¥2.75 Million 0.003x +119.01%
2014-12-31 CN¥1.47 Billion CN¥-20.22 Million -0.014x +28.32%
2013-12-31 CN¥1.47 Billion CN¥-28.16 Million -0.019x +88.62%
2012-12-31 CN¥1.63 Billion CN¥-276.02 Million -0.169x -561.92%
2011-12-31 CN¥1.80 Billion CN¥65.88 Million 0.037x -43.78%
2010-12-31 CN¥1.61 Billion CN¥104.63 Million 0.065x -79.05%
2009-12-31 CN¥1.02 Billion CN¥316.73 Million 0.310x +61.84%
2008-12-31 CN¥776.46 Million CN¥148.93 Million 0.192x +72.98%
2007-12-31 CN¥742.02 Million CN¥82.28 Million 0.111x +181.49%
2006-12-31 CN¥892.18 Million CN¥35.14 Million 0.039x -26.41%
2005-12-31 CN¥874.86 Million CN¥46.83 Million 0.054x +64.59%
2004-12-31 CN¥893.38 Million CN¥29.05 Million 0.033x -80.35%
2003-12-31 CN¥904.58 Million CN¥149.70 Million 0.165x -24.57%
2002-12-31 CN¥834.94 Million CN¥183.18 Million 0.219x +172.54%
2001-12-31 CN¥755.58 Million CN¥60.82 Million 0.081x -35.25%
2000-12-31 CN¥751.40 Million CN¥93.41 Million 0.124x +65.11%
1999-12-31 CN¥703.50 Million CN¥52.97 Million 0.075x -52.56%
1998-12-31 CN¥448.25 Million CN¥71.14 Million 0.159x --